Altitude Crest Partners as of Dec. 31, 2023
Portfolio Holdings for Altitude Crest Partners
Altitude Crest Partners holds 12 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Legend Biotech Corp Sponsored Ads (LEGN) | 21.8 | $33M | 542k | 60.17 | |
| Bridgebio Pharma (BBIO) | 20.4 | $31M | 755k | 40.37 | |
| Danaher Corporation (DHR) | 18.8 | $28M | 122k | 231.34 | |
| Argenx Se Sponsored Adr (ARGX) | 7.5 | $11M | 30k | 380.43 | |
| BioMarin Pharmaceutical (BMRN) | 7.4 | $11M | 114k | 96.42 | |
| Apellis Pharmaceuticals (APLS) | 6.1 | $9.1M | 152k | 59.86 | |
| Roivant Sciences SHS (ROIV) | 6.1 | $9.1M | 808k | 11.23 | |
| Kiniksa Pharmaceuticals Com Cl A | 5.4 | $8.0M | 456k | 17.54 | |
| EXACT Sciences Corporation (EXAS) | 4.9 | $7.3M | 99k | 73.98 | |
| Aligos Therapeutics (ALGS) | 1.3 | $1.9M | 2.8M | 0.66 | |
| Ambrx Biopharma | 0.4 | $614k | 43k | 14.24 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $7.7k | 385k | 0.02 |
